Osteoporosis: head-to-head trial compares teriparatide injection with oral risedronate

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Vertebral fracture risk is lower in patients receiving teriparatide injection (Forteo) compared with oral risedronate (Actonel) among patients with osteoporosis.

Why this matters

  • Prior head-to-head trials have not directly compared these 2 drugs...